Noncompetitive antagonism and inverse agonism as mechanism of action of nonpeptidergic antagonists at primate and rodent CXCR3 chemokine receptors - Wikidata - awgldk - TriplyDB

Noncompetitive antagonism and inverse agonism as mechanism of action of nonpeptidergic antagonists at primate and rodent CXCR3 chemokine receptors

Noncompetitive antagonism and inverse agonism as mechanism of action of nonpeptidergic antagonists at primate and rodent CXCR3 chemokine receptors

http://www.wikidata.org/entity/Q36859581

about

Ubiquitination of CXCR7 controls receptor trafficking Identification and characterization of circulating variants of CXCL12 from human plasma: effects on chemotaxis and mobilization of hematopoietic stem and progenitor cells.Pharmacological characterization of a small-molecule agonist for the chemokine receptor CXCR3 The Epstein-Barr virus-encoded G protein-coupled receptor BILF1 hetero-oligomerizes with human CXCR4, scavenges Gαi proteins, and constitutively impairs CXCR4 functioning.CXCR3 antagonism of SDF-1(5-67) restores trabecular function and prevents retinal neurodegeneration in a rat model of ocular hypertension.Chemokine receptor CXCR3 promotes growth of glioma.CXCR3 antagonist VUF10085 binds to an intrahelical site distinct from that of the broad spectrum antagonist TAK-779.Real-time characterization of cannabinoid receptor 1 (CB1 ) allosteric modulators reveals novel mechanism of action.Chemokine-directed strategies to attenuate allograft rejection.Current status and challenges of cytokine pharmacology.Chemokine receptor antagonists: part 2.Pharmacological modulation of chemokine receptor function.Successes and failures of chemokine-pathway targeting in rheumatoid arthritis.Designing small molecule CXCR3 antagonists.Identification and profiling of CXCR3-CXCR4 chemokine receptor heteromer complexes.Novel Human Cytomegalovirus Viral Chemokines, vCXCL-1s, Display Functional Selectivity for Neutrophil Signaling and Function.Metabolic profiling of ligands for the chemokine receptor CXCR3 by liquid chromatography-mass spectrometry coupled to bioaffinity assessment.Inhibition of CXCR3-mediated chemotaxis by the human chemokine receptor-like protein CCX-CKR.Neutralizing nanobodies targeting diverse chemokines effectively inhibit chemokine function 'Neuroinflammation' differs categorically from inflammation: transcriptomes of Alzheimer's disease, Parkinson's disease, schizophrenia and inflammatory diseases compared.

P2860

Q24310278-FC75C4D2-0A28-45AF-9A94-99F7030E92DE Q33998570-8D4E4828-2B59-45D3-8D1C-696AAE7D7432 Q34007358-20B0BE72-1D54-4B76-AA83-206668B08C20 Q34121692-BD71F0F2-6CE3-4A36-9CAD-DC103F87FA88 Q34295638-5BF66834-36DC-4AA3-AB3D-F16BF3B16A49 Q34520386-1539E38D-A2C9-433D-A23B-FA8C56E9A30B Q35223948-D513966E-87B7-42AF-8193-F2A434AF7FAC Q37237174-D4212DB4-DA98-4022-A488-399EF1DB4595 Q37332946-8DF53C43-59CA-4350-8B7E-BA635DC7A3C0 Q37445966-8BCFDD81-F856-4B0A-8B04-91A3A90DA52F Q37481304-DD8B3557-EBC1-4FC4-961A-2355BB55559E Q37893687-55768074-6938-4B50-99B6-B27B2BAB86AE Q38647749-6CE437D5-6F63-4323-ADC8-3B339EA53E11 Q39051765-82E7EB11-5602-4702-BC44-1D271526C5FB Q39210261-319C6D19-E051-4CD1-97D0-142C425B5787 Q40925445-46A93A5C-7069-4E3F-A020-0BD116A63334 Q41113403-8DB5B598-CFAD-499C-AF13-D929B9BEFAC8 Q41164568-98A01002-1CCD-4220-BC87-9D751010EF43 Q41861205-727FF0E2-A297-4356-BAFC-8B33273640C4 Q44817276-FE339465-1808-4456-9E43-908CA304752D

P2860

Noncompetitive antagonism and inverse agonism as mechanism of action of nonpeptidergic antagonists at primate and rodent CXCR3 chemokine receptors

http://www.wikidata.org/entity/Q36859581

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Noncompetitive antagonism and ...... dent CXCR3 chemokine receptors

@en

type

label

Noncompetitive antagonism and ...... dent CXCR3 chemokine receptors

@en

prefLabel

Noncompetitive antagonism and ...... dent CXCR3 chemokine receptors

@en

P1433

Q36859581-95263F8C-2C09-4047-BD6F-1756867EA243

P1476

Q36859581-1927B7FC-7FEC-4928-A647-593E75CBBA6E

P2093

Q36859581-038D82CC-8B2F-4ACE-92E7-2236F1A2E10E

Q36859581-2D888DAB-2079-4547-A245-66D037A691DE

Q36859581-383685FC-6A40-4AC3-8C80-93C9A97167F4

Q36859581-523F6141-EA75-424A-BD75-BA54801A3FEE

Q36859581-7C187779-F8D6-4C9A-8A67-A8FDA111E927

Q36859581-88D2A186-A01A-4916-90F9-F2F12A23B213

Q36859581-8E3D89AD-583F-4AC7-A0F0-161EC7838291

Q36859581-92B008C3-EF83-4F87-96F0-D263B2966729

Q36859581-967B69DF-F6FF-48FE-ADDE-82947B2C8FE2

Q36859581-9D6552AD-1817-47D1-8588-31BAEB143EC1

P2860

Q36859581-0B2DF372-F0F3-40A6-B04B-263C6599BA78

Q36859581-17EFCEA4-85F2-4356-A0B2-23FF39333D72

Q36859581-1B2E2C38-989C-461E-AA0A-9FFA12161F4D

Q36859581-2197B5AE-324C-4668-A363-C5273473AD01

Q36859581-26C5FC7D-CDD7-4458-BCC0-B8CBBCB589A7

Q36859581-2BBD4C94-08A9-4240-85AD-DF640018498A

Q36859581-32047A15-F869-4F0E-8D64-E67788B3FB91

Q36859581-3972C069-925D-4C11-9F8F-178A27C203CC

Q36859581-3AD15A42-32AF-4037-BD6D-A9ADD4C4E774

Q36859581-401ECF1F-DC0A-43C9-A3C5-A9BBC3A6D5FD

P304

Q36859581-875089DC-BB3D-4346-8369-57AE258F4D23

P31

Q36859581-CAA8BCBB-640A-44A0-A885-B61DBE0A2CA9

P356

Q36859581-27666370-2BEB-4540-A4A7-723043736177

P407

Q36859581-A6EB4A89-A232-45C7-A267-9958A82BC46D

P433

Q36859581-74319677-26B4-4C69-8919-5690410D8946

P478

Q36859581-B13019DE-7417-4DE6-BAF4-99AFDCB79893

P577

Q36859581-0A2AE080-DDB4-480F-AD7D-15A24521E8A8

P5875

Q36859581-20D29209-B34F-47EB-A8E9-5DEC35D76C0C

P698

Q36859581-E7A0B7B5-2087-430F-9138-A5C691C6A1AD

P932

Q36859581-23A2EF08-294C-4399-9307-6201E5BBD66C

P356

JPET.107.134783

P1433

Journal of Pharmacology and Experimental Therapeutics

P1476

Noncompetitive antagonism and ...... dent CXCR3 chemokine receptors

@en

P2093

Carlos P Fitzsimons

http://www.w3.org/2001/XMLSchema#string

Cornelis P Tensen

http://www.w3.org/2001/XMLSchema#string

Daniel N Streblow

http://www.w3.org/2001/XMLSchema#string

Danny J Scholten

http://www.w3.org/2001/XMLSchema#string

Dennis Verzijl

http://www.w3.org/2001/XMLSchema#string

Guido J R Zaman

http://www.w3.org/2001/XMLSchema#string

Iwan J P de Esch

http://www.w3.org/2001/XMLSchema#string

James E Pease

http://www.w3.org/2001/XMLSchema#string

Leontien Bosch

http://www.w3.org/2001/XMLSchema#string

Martine J Smit

http://www.w3.org/2001/XMLSchema#string

P2860

Point mutation causing constitutive signaling of CXCR2 leads to transforming activity similar to Kaposi's sarcoma herpesvirus-G protein-coupled receptor

Chemokine receptor responses on T cells are achieved through regulation of both receptor expression and signaling

Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes

Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells

Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients

The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions

Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3

Requirement of the chemokine receptor CXCR3 for acute allograft rejection

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

International union of pharmacology. XXII. Nomenclature for chemokine receptors

P304

544-555

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1124/JPET.107.134783

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

325

http://www.w3.org/2001/XMLSchema#string

P577

2008-02-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5582429

http://www.w3.org/2001/XMLSchema#string

P698

18270317

http://www.w3.org/2001/XMLSchema#string

P932

3659174

http://www.w3.org/2001/XMLSchema#string